From baseline to study end , both treatment interventions resulted in a significant reduction of androstenedione ( P = .013 ) , free T ( P = .002 ) , and homeostasis model assessment for insulin resistance score ( P = .027 ) and a significant increase in SHBG ( P = .024 ) , although the between-treatment differences of the changes have not been statistically significant yet .